A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350
Clinical trial NCT02983227 · COMPLETED
Trial details
- NCT number
- NCT02983227
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2019-07-17
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.